Pediatric Vaccines Market Size, Share, Growth, Analysis, 2034

Monovalent
Multivalent

Live Attenuated Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
Conjugate Vaccines
Others

Infectious Disease
Cancer
Allergy
Pneumococcal Diseases
Influenza
Measles, Mumps, and Rubella (MMR)
Others

North America
1. North America Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
  1. Monovalent
  2. Multivalent
2. North America Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
  1. Live Attenuated Vaccines
  2. Inactivated Vaccines
  3. Subunit Vaccines
  4. Toxoid Vaccines
  5. Conjugate Vaccines
  6. Others
3. North America Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
  1. Infectious Disease
  2. Cancer
  3. Allergy
  4. Pneumococcal Diseases
  5. Influenza
  6. Measles, Mumps, and Rubella (MMR)
  7. Others
4. U.S. Pediatric Vaccines Market
  1. U.S. Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. U.S. Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. U.S. Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
5. Canada Pediatric Vaccines Market
  1. Canada Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Canada Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Canada Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
Europe
1. Europe Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
  1. Monovalent
  2. Multivalent
2. Europe Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
  1. Live Attenuated Vaccines
  2. Inactivated Vaccines
  3. Subunit Vaccines
  4. Toxoid Vaccines
  5. Conjugate Vaccines
  6. Others
3. Europe Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
  1. Infectious Disease
  2. Cancer
  3. Allergy
  4. Pneumococcal Diseases
  5. Influenza
  6. Measles, Mumps, and Rubella (MMR)
  7. Others
4. U.K. Pediatric Vaccines Market
  1. U.K. Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. U.K. Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. U.K. Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
5. Germany Pediatric Vaccines Market
  1. Germany Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Germany Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Germany Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
6. France Pediatric Vaccines Market
  1. France Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. France Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. France Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
7. Spain Pediatric Vaccines Market
  1. Spain Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Spain Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Spain Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
8. Italy Pediatric Vaccines Market
  1. Italy Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Italy Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Italy Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
9. Russia Pediatric Vaccines Market
  1. Russia Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Russia Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Russia Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
10. Nordic Pediatric Vaccines Market
  1. Nordic Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Nordic Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Nordic Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
11. Benelux Pediatric Vaccines Market
  1. Benelux Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Benelux Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Benelux Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
12. Rest of Europe Pediatric Vaccines Market
  1. Rest of Europe Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Rest of Europe Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Rest of Europe Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
APAC
1. APAC Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
  1. Monovalent
  2. Multivalent
2. APAC Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
  1. Live Attenuated Vaccines
  2. Inactivated Vaccines
  3. Subunit Vaccines
  4. Toxoid Vaccines
  5. Conjugate Vaccines
  6. Others
3. APAC Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
  1. Infectious Disease
  2. Cancer
  3. Allergy
  4. Pneumococcal Diseases
  5. Influenza
  6. Measles, Mumps, and Rubella (MMR)
  7. Others
4. China Pediatric Vaccines Market
  1. China Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. China Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. China Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
5. Korea Pediatric Vaccines Market
  1. Korea Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Korea Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Korea Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
6. Japan Pediatric Vaccines Market
  1. Japan Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Japan Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Japan Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
7. India Pediatric Vaccines Market
  1. India Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. India Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. India Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
8. Australia Pediatric Vaccines Market
  1. Australia Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Australia Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Australia Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
9. Taiwan Pediatric Vaccines Market
  1. Taiwan Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Taiwan Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Taiwan Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
10. South East Asia Pediatric Vaccines Market
  1. South East Asia Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. South East Asia Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. South East Asia Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
11. Rest of Asia-Pacific Pediatric Vaccines Market
  1. Rest of Asia-Pacific Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Rest of Asia-Pacific Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Rest of Asia-Pacific Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
Middle East and Africa
1. Middle East and Africa Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
  1. Monovalent
  2. Multivalent
2. Middle East and Africa Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
  1. Live Attenuated Vaccines
  2. Inactivated Vaccines
  3. Subunit Vaccines
  4. Toxoid Vaccines
  5. Conjugate Vaccines
  6. Others
3. Middle East and Africa Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
  1. Infectious Disease
  2. Cancer
  3. Allergy
  4. Pneumococcal Diseases
  5. Influenza
  6. Measles, Mumps, and Rubella (MMR)
  7. Others
4. UAE Pediatric Vaccines Market
  1. UAE Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. UAE Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. UAE Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
5. Turkey Pediatric Vaccines Market
  1. Turkey Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Turkey Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Turkey Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
6. Saudi Arabia Pediatric Vaccines Market
  1. Saudi Arabia Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Saudi Arabia Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Saudi Arabia Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
7. South Africa Pediatric Vaccines Market
  1. South Africa Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. South Africa Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. South Africa Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
8. Egypt Pediatric Vaccines Market
  1. Egypt Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Egypt Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Egypt Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
9. Nigeria Pediatric Vaccines Market
  1. Nigeria Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Nigeria Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Nigeria Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
10. Rest of MEA Pediatric Vaccines Market
  1. Rest of MEA Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Rest of MEA Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Rest of MEA Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
LATAM
1. LATAM Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
  1. Monovalent
  2. Multivalent
2. LATAM Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
  1. Live Attenuated Vaccines
  2. Inactivated Vaccines
  3. Subunit Vaccines
  4. Toxoid Vaccines
  5. Conjugate Vaccines
  6. Others
3. LATAM Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
  1. Infectious Disease
  2. Cancer
  3. Allergy
  4. Pneumococcal Diseases
  5. Influenza
  6. Measles, Mumps, and Rubella (MMR)
  7. Others
4. Brazil Pediatric Vaccines Market
  1. Brazil Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Brazil Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Brazil Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
5. Mexico Pediatric Vaccines Market
  1. Mexico Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Mexico Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Mexico Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
6. Argentina Pediatric Vaccines Market
  1. Argentina Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Argentina Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Argentina Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
7. Chile Pediatric Vaccines Market
  1. Chile Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Chile Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Chile Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
8. Colombia Pediatric Vaccines Market
  1. Colombia Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Colombia Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Colombia Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others
9. Rest of LATAM Pediatric Vaccines Market
  1. Rest of LATAM Pediatric Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Rest of LATAM Pediatric Vaccines Market By Technology 2022-2034 (USD MILLION/ Units)
    1. Live Attenuated Vaccines
    2. Inactivated Vaccines
    3. Subunit Vaccines
    4. Toxoid Vaccines
    5. Conjugate Vaccines
    6. Others
  3. Rest of LATAM Pediatric Vaccines Market By Application 2022-2034 (USD MILLION/ Units)
    1. Infectious Disease
    2. Cancer
    3. Allergy
    4. Pneumococcal Diseases
    5. Influenza
    6. Measles, Mumps, and Rubella (MMR)
    7. Others

Market Segmentation